At a glance
- Originator Ono Pharmaceutical
- Class Neuroprotectants; Nootropics; Pyrrolidines; Small molecules
- Mechanism of Action Prolyl endopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.